New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - fludarabine phosphate 10mg - film coated tablet - 10 mg - active: fludarabine phosphate 10mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - the treatment of b-cell chronic lympocytic leukaemia.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - fludarabine phosphate - powder for solution for injection/infusion - 50 milligram(s) - purine analogues; fludarabine

Malta - English - Malta Medicines Authority

genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents

Malta - English - Malta Medicines Authority

genzyme europe bv paasheuvelweg 25, 1105 bp amsterdam , netherlands - fludarabine phosphate - film-coated tablet - fludarabine phosphate 10 mg - antineoplastic agents

Malta - English - Malta Medicines Authority

accord healthcare limited - fludarabine phosphate - concentrate for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents

Malta - English - Malta Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - fludarabine phosphate - powder for solution for infusion or injection - fludarabine phosphate 50 mg - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - fludarabine phosphate, quantity: 50 mg - injection, powder for - excipient ingredients: mannitol; sodium hydroxide - treatment of b-cell chronic lymphocytic leukaemia

Malta - English - Malta Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - fludarabine phosphate - concentrate for solution for infusion or injection - fludarabine phosphate 25 mg/ml - antineoplastic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - fludarabine phosphate 25 mg/ml;   - powder for injection - 50 mg/2ml - active: fludarabine phosphate 25 mg/ml   excipient: mannitol sodium hydroxide

Ireland - English - HPRA (Health Products Regulatory Authority)

genzyme europe b.v. - fludarabine phosphate - powder for solution for injection/infusion - 50 milligram(s) - purine analogues; fludarabine